Authors


Howard B. Moss, MD

Latest:

Medical Marijuana and Mental Health: Cannabis Use in Psychiatric Practice

Here's why psychiatrists and other mental health professionals need to understand the relationship between cannabis and mental disorders.


Howard C. Margolese, MD, MSc, FRCPC

Latest:

Introduction: Strategies for Treatment

When thinking about recent advances in psychopharmacology, we often point to new molecules with similar mechanisms of action but with better safety and tolerability profiles, or to molecules with novel mechanisms that effect positive change greater than that with existing treatments.


Howard D. Weiss, MD

Latest:

Management of Psychosis in Parkinson Disease

For some patients with Parkinson disease, the neuropsychiatric complications are a greater source of morbidity than the motor dysfunction. This article focuses on the management of psychosis in Parkinson disease.


Howard Gardner

Latest:

Intelligence Reframed: Multiple Intelligences for the 21st Century

People are different, according to conventional wisdom - the saying generally used in explaining varying opinions, attitudes or ways of thinking. Why then is it not a given that people are different in basic brain functions such as learning and intelligence?


Howard J. Shaffer, PhD

Latest:

Is Computer Addiction a Unique Psychiatric Disorder?

Although it may be tempting to say that almost any rewarding activity can become addicting, new research appears to indicate that, at least in the case of Internet use, that may not be the case. In fact, "Internet addiction" may actually be a sign for other psychiatric disorders.


Howard L. Forman, MD

Latest:

Avoiding the Path of Least Resistance

In this insightful interview, experts discuss the journey toward a more humanistic approach in psychiatry, the challenges of integrating biological and psychosocial aspects, and the need for comprehensive training for future psychiatrists.


Howard S. Rossman, DO

Latest:

Setting Up a Neurology-Based Infusion Center: Rationale and Guidelines

"No longer a pipe dream," is the suggestive lead-in of a widely distributed press release issued last October touting the potential benefits of cannabinoid compounds in the treatment of Parkinson disease (PD), Lou Gehrig disease-or amyotrophic lateral sclerosis (ALS)-and a number of other debilitating conditions, as reported during last fall's 2004 annual meeting of the Society for Neuroscience. According to Daniele Piomelli, PhD, an expert in cannabinoid research and professor in the Department of Pharmacology at the University of California, Irvine, certain cannabinoid compounds can be harnessed to "provide select benefits to patients while avoiding some of the unwanted effects" associated with marijuana use. Compounds of greatest interest have been WIN 55212-2, delta(9)-tetrahydrocannabinol (THC), and anandamide.


Howard Spivak, MD

Latest:

An Early Warning Sign for Violence

Bullying and being bullied put adolescents at risk for developing violent behaviors. Depression and anxiety are two of the underlying issues related to this type of behavior. Recognizing the warning signs may help mental health care professionals prevent violence in the adolescent's life.


Hua Jin, MD

Latest:

Glucose Dysregulation

The atypical antipsychotics have become the treatment of choice for patients with psychotic and other behavioral disorders. However, case reports, retrospective studies and epidemiological data suggest that these medications may be associated with new-onset type 2 diabetes and diabetic ketoacidosis.


Hugh Myrick, MD

Latest:

The Diagnosis and Treatment of Substance Abuse/ Dependence and Co-Occurring Social Anxiety Disorder

Social anxiety disorder and drug addiction commonly co-occur in the same individual, complicating the presentation, course and treatment of both disorders. Using drugs or alcohol may be a coping mechanism for social anxiety; however, many treatments for addiction are group-based approaches, which would be especially challenging for people with social anxiety disorder. This article provides a brief overview of what is known about the co-occurrence of these disorders, as well as possible treatment interventions for this population.


Humberto Marin, MD

Latest:

Unexplained Physical Symptoms

he key manifestations of DSM-IV somatoform disorder are unexplained physical symptoms or complaints that tend to coexist with other psychiatric syndromes or are linked to psychological issues. These symptoms typically lead to repeated medical or emergency department visits; are associated with serious discomfort, dysfunction, and disability; and lead to significant health expenditures.


Hunter L. McQuistion, MD

Latest:

Outside the Pill Box: The Systems-Based Practice of Psychiatry

Meet "Gary," whose case provides an introduction to the value of systems-based practice.


Hussam Jefee-Bahloul, MD

Latest:

Pharmacogenetics to Predict Treatment Outcome in Substance Use Disorders

This brief communication highlights the importance of genetic predictors and moderators of treatment research in the field of substance use.


Husseini K. Manji, MD

Latest:

Digital Health as an Enabler for Patient-Centric, Outcome-Based Care

Considering challenges and opportunities in digital health solutions for mental health care.


Hy Bloom, MD

Latest:

Managing the Aftermath of Patient-on-Staff Violence

Violence by patients towards staff members is an inherently complex matter for the physically and/or psychologically injured person. An expert in the field of forensic psychiatry answers a reader's question about what clinicians can do in the aftermath of an assault.


Ian Alger, MD

Latest:

Creative Media in Psychotherapy

Nonverbal cues speak just as loudly as words. How can video be used to capture these subtle cues and help patients make progress in therapy?


Icelini Garcia-sosa, MD

Latest:

Reasons Patients Doubt Medication-Resistant Delusions in Schizophrenia

Our study suggests that most delusional patients, even those with high positive symptom scores, may have at least 1 RFD that precedes a clinical intervention specifically directed toward encouraging doubt. These preexisting “islands of doubt” may offer a useful foothold to begin the CBT process.


Ida Orengo, MD

Latest:

Psychocutaneous Disorders

Psychological problems are often manifest in the skin. In fact, it is estimated that between 20% and 30% of all skin disorders have some psychological component. Many patients who have psychocutaneous disorders-which are often direct evidence of or secondary to psychological abberations-drift from one physician to another, trying to find one savvy enough to cure their “skin condition.” Furthermore, although they have sought many medical opinions already, patients afflicted with psychocutaneous disorders almost always present as “an emergency.” While pharmacological intervention may benefit such patients, traditional mental health interventions are almost always required if the aberrant behavior is to cease.


Igor I. Galynker, MD, PhD

Latest:

Violence in Bipolar Disorder

What is the association between bipolar disorder, trauma, and violence? Here: a guide to assessing violence potential in bipolar patients.


Ihsan Salloum, MD, MPH

Latest:

Mini Quiz: DSM-5 Basics

DSM-5 stands out for the introduction of several new specifiers, which will allow for more accurate coding. Which of the items mentioned in this quiz did not change in DSM-5?


Ike Devji, JD

Latest:

Take 5 Before You Give 5: The Dos and Don’ts of Political Contributions

Common legal questions about political donations are discussed.


Ilana Braun, MD

Latest:

Issues in Psycho-Oncology: What Clinicians Need to Know

An overview of select topics in clinical psycho-oncology, including assessment and management of delirium and brain lesions, mood and anxiety disorders, medication adverse effects, and existential death anxiety.


Ileana Berman, MD

Latest:

Obsessive-Compulsive Symptoms in Schizophrenia

There is currently great controversy over the issue of obsessive-compulsive behaviors in schizophrenia. Are patients who display these behaviors suffering from a separate subtype of schizophrenia?


Ilise Lombardo, MD

Latest:

Cognitive Impairment in Patients With Bipolar Disorder

It is widely accepted that patients with schizophrenia have some degree of cognitive deficiency and that cognitive deficits are an inherent part of the disorder. Historically, there has been less focus on cognitive deficits in patients with bipolar disorder; however, numerous studies of cognition in patients with bipolar disorder, including several comprehensive meta-analyses of bipolar patients who were euthymic at the time of testing, have recently been undertaken.1-4 Each of these analyses found that cognitive impairment persists during periods of remission, mainly in domains that include attention and processing speed, memory, and executive functioning.4


Ilya Kister, MD

Latest:

Neoplasm or Demyelinating Lesion?

A 32-year-old left-handed woman presented with a 4-week history of progressive left hand numbness, tingling, and clumsiness. Symptoms worsened until she found it difficult to write and perform fine motor tasks. She reported having no transient neurological symptoms in the past. Her medical history was significant only for Dengue fever acquired several years ago while on a visit to Southeast Asia. She was taking no medications, and a review of systems was noncontributory.


Iman Parhami, MD, MPH

Latest:

A Case of Gambling Disorder

A patient is brought to the emergency department by her daughter for bizarre behavior and symptoms of mania after gambling from the casino for 48 continuous hours.



Ingrid Vasiliu-Feltes, MD, MBA

Latest:

Mini Quiz: DSM-5 Basics

DSM-5 stands out for the introduction of several new specifiers, which will allow for more accurate coding. Which of the items mentioned in this quiz did not change in DSM-5?


Ioline D. Henter, MA

Latest:

New Drug Developments for Bipolar Mania

While challenges in treating mania persist, the future discovery of novel therapeutic agents will likely expand our understanding of this devastating illness and provide key insights into future drug development.


Ipsit Vahia, MD

Latest:

The Intersection of Mental Health and Successful Aging

One consequence of the "graying" of the world's population is that psychiatrists, along with all health care professionals, will increasingly be providing services to older adults. In the United States, the first set of people belonging to the baby boom generation turned 60 in 2005, and the number of people older than 60 will soonoutnumber children for the first time in recorded history.

© 2024 MJH Life Sciences

All rights reserved.